Cytokinetics (CYTK) stock ends 2025 higher as Myqorzo launch nears — what’s next
Cytokinetics, Incorporated shares rose $2.17, or 3.5%, to $63.54 in the last trading session of 2025, after swinging between $60.93 and $64.43 on volume of about 1.85 million shares. U.S. markets were shut on Thursday for the New Year’s Day holiday. Yahoo Finance
